Ficović P, Gjurić Z, Grgić Z
Bilt Hematol Transfuz. 1978;6(2):49-55.
The laboratory examination of Dipyridamole concerning its antiaggregation effect is presented in the paper. Thirty patients with coronary insufficiency have been taking Dipyridamole for one year. The average dosage was four pills à 75 mg of Dipyridamole a day. The aggregation and adhesion of the platelets with the examined patients was checked before and during the treatment. The inhibition platelet aggregation with Dipyridamole has been confirmed in vitro.
本文介绍了双嘧达莫抗聚集作用的实验室检查。30例冠状动脉供血不足患者服用双嘧达莫一年。平均剂量为每天4片,每片含双嘧达莫75毫克。在治疗前和治疗期间检查了受试患者血小板的聚集和黏附情况。双嘧达莫对血小板聚集的抑制作用已在体外得到证实。